- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biopharmaceutical Contract Manufacturing market report explains the definition, types, applications, major countries, and major players of the Biopharmaceutical Contract Manufacturing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Probiogen
Biomeva
Fujifilm Diosynth Biotechnologies
Abzena
Lonza Group
KBI Biopharma
Cytovance Biologics
Rentschler Biotechnologie
Samsung
Patheon
Baxter Biopharma Solutions
WuXi Biologics
Boehringer Ingelheim
By Type:
Growth Factors
Interferons
Monoclonal Antibodies
Recombinant Hormones
Vaccines
Insulin
Others
By End-User:
Autoimmune Diseases
Oncology
Metabolic Diseases
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Neurology
Respiratory Disorders
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Biopharmaceutical Contract Manufacturing Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Biopharmaceutical Contract Manufacturing Outlook to 2028- Original Forecasts
-
2.2 Biopharmaceutical Contract Manufacturing Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Biopharmaceutical Contract Manufacturing Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Biopharmaceutical Contract Manufacturing Market- Recent Developments
-
6.1 Biopharmaceutical Contract Manufacturing Market News and Developments
-
6.2 Biopharmaceutical Contract Manufacturing Market Deals Landscape
7 Biopharmaceutical Contract Manufacturing Raw Materials and Cost Structure Analysis
-
7.1 Biopharmaceutical Contract Manufacturing Key Raw Materials
-
7.2 Biopharmaceutical Contract Manufacturing Price Trend of Key Raw Materials
-
7.3 Biopharmaceutical Contract Manufacturing Key Suppliers of Raw Materials
-
7.4 Biopharmaceutical Contract Manufacturing Market Concentration Rate of Raw Materials
-
7.5 Biopharmaceutical Contract Manufacturing Cost Structure Analysis
-
7.5.1 Biopharmaceutical Contract Manufacturing Raw Materials Analysis
-
7.5.2 Biopharmaceutical Contract Manufacturing Labor Cost Analysis
-
7.5.3 Biopharmaceutical Contract Manufacturing Manufacturing Expenses Analysis
8 Global Biopharmaceutical Contract Manufacturing Import and Export Analysis (Top 10 Countries)
-
8.1 Global Biopharmaceutical Contract Manufacturing Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Biopharmaceutical Contract Manufacturing Export by Region (Top 10 Countries) (2017-2028)
9 Global Biopharmaceutical Contract Manufacturing Market Outlook by Types and Applications to 2022
-
9.1 Global Biopharmaceutical Contract Manufacturing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Growth Factors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Interferons Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Recombinant Hormones Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Insulin Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Biopharmaceutical Contract Manufacturing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Metabolic Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Ophthalmology Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Neurology Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Respiratory Disorders Consumption and Growth Rate (2017-2022)
-
9.2.9 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Biopharmaceutical Contract Manufacturing Market Analysis and Outlook till 2022
-
10.1 Global Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.2.2 Canada Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.2.3 Mexico Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.2 UK Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.3 Spain Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.4 Belgium Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.5 France Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.6 Italy Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.7 Denmark Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.8 Finland Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.9 Norway Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.10 Sweden Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.11 Poland Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.12 Russia Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.3.13 Turkey Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.2 Japan Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.3 India Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.4 South Korea Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.5 Pakistan Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.6 Bangladesh Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.7 Indonesia Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.8 Thailand Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.9 Singapore Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.10 Malaysia Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.11 Philippines Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.4.12 Vietnam Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.5.2 Colombia Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.5.3 Chile Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.5.4 Argentina Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.5.5 Venezuela Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.5.6 Peru Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.5.7 Puerto Rico Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.5.8 Ecuador Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.6.2 Kuwait Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.6.3 Oman Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.6.4 Qatar Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.6.5 Saudi Arabia Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.6.6 United Arab Emirates Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.7.2 South Africa Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.7.3 Egypt Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.7.4 Algeria Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
-
10.8.2 New Zealand Biopharmaceutical Contract Manufacturing Consumption (2017-2022)
11 Global Biopharmaceutical Contract Manufacturing Competitive Analysis
-
11.1 Probiogen
-
11.1.1 Probiogen Company Details
-
11.1.2 Probiogen Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Probiogen Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.1.4 Probiogen Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Biomeva
-
11.2.1 Biomeva Company Details
-
11.2.2 Biomeva Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Biomeva Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.2.4 Biomeva Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Fujifilm Diosynth Biotechnologies
-
11.3.1 Fujifilm Diosynth Biotechnologies Company Details
-
11.3.2 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.3.4 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Abzena
-
11.4.1 Abzena Company Details
-
11.4.2 Abzena Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Abzena Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.4.4 Abzena Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Lonza Group
-
11.5.1 Lonza Group Company Details
-
11.5.2 Lonza Group Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Lonza Group Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.5.4 Lonza Group Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 KBI Biopharma
-
11.6.1 KBI Biopharma Company Details
-
11.6.2 KBI Biopharma Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.6.4 KBI Biopharma Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Cytovance Biologics
-
11.7.1 Cytovance Biologics Company Details
-
11.7.2 Cytovance Biologics Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.7.4 Cytovance Biologics Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Rentschler Biotechnologie
-
11.8.1 Rentschler Biotechnologie Company Details
-
11.8.2 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.8.4 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Samsung
-
11.9.1 Samsung Company Details
-
11.9.2 Samsung Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Samsung Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.9.4 Samsung Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Patheon
-
11.10.1 Patheon Company Details
-
11.10.2 Patheon Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Patheon Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.10.4 Patheon Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Baxter Biopharma Solutions
-
11.11.1 Baxter Biopharma Solutions Company Details
-
11.11.2 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.11.4 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 WuXi Biologics
-
11.12.1 WuXi Biologics Company Details
-
11.12.2 WuXi Biologics Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.12.4 WuXi Biologics Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Boehringer Ingelheim
-
11.13.1 Boehringer Ingelheim Company Details
-
11.13.2 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
11.13.4 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Biopharmaceutical Contract Manufacturing Market Outlook by Types and Applications to 2028
-
12.1 Global Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Growth Factors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Interferons Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Recombinant Hormones Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Metabolic Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.7 Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.8 Global Respiratory Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.9 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Biopharmaceutical Contract Manufacturing Market Analysis and Outlook to 2028
-
13.1 Global Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.2.2 Canada Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.2.3 Mexico Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.2 UK Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.3 Spain Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.4 Belgium Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.5 France Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.6 Italy Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.7 Denmark Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.8 Finland Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.9 Norway Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.10 Sweden Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.11 Poland Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.12 Russia Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.3.13 Turkey Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.2 Japan Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.3 India Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.4 South Korea Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.8 Thailand Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.9 Singapore Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.11 Philippines Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.5.2 Colombia Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.5.3 Chile Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.5.4 Argentina Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.5.6 Peru Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.6.3 Oman Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.6.4 Qatar Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.7.2 South Africa Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.7.3 Egypt Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.7.4 Algeria Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Biopharmaceutical Contract Manufacturing Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Biopharmaceutical Contract Manufacturing
-
Figure of Biopharmaceutical Contract Manufacturing Picture
-
Table Global Biopharmaceutical Contract Manufacturing Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Biopharmaceutical Contract Manufacturing Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Growth Factors Consumption and Growth Rate (2017-2022)
-
Figure Global Interferons Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Hormones Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Ophthalmology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Neurology Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Biopharmaceutical Contract Manufacturing Consumption by Country (2017-2022)
-
Table North America Biopharmaceutical Contract Manufacturing Consumption by Country (2017-2022)
-
Figure United States Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Canada Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Mexico Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Table Europe Biopharmaceutical Contract Manufacturing Consumption by Country (2017-2022)
-
Figure Germany Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure UK Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Spain Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Belgium Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure France Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Italy Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Denmark Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Finland Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Norway Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Sweden Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Poland Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Russia Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Turkey Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Table APAC Biopharmaceutical Contract Manufacturing Consumption by Country (2017-2022)
-
Figure China Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Japan Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure India Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Thailand Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Singapore Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Philippines Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Table South America Biopharmaceutical Contract Manufacturing Consumption by Country (2017-2022)
-
Figure Brazil Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Colombia Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Chile Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Argentina Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Peru Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Table GCC Biopharmaceutical Contract Manufacturing Consumption by Country (2017-2022)
-
Figure Bahrain Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Oman Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Qatar Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Table Africa Biopharmaceutical Contract Manufacturing Consumption by Country (2017-2022)
-
Figure Nigeria Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure South Africa Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Egypt Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Algeria Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Table Oceania Biopharmaceutical Contract Manufacturing Consumption by Country (2017-2022)
-
Figure Australia Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Biopharmaceutical Contract Manufacturing Consumption and Growth Rate (2017-2022)
-
Table Probiogen Company Details
-
Table Probiogen Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Probiogen Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Probiogen Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table Biomeva Company Details
-
Table Biomeva Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biomeva Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Biomeva Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table Fujifilm Diosynth Biotechnologies Company Details
-
Table Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table Abzena Company Details
-
Table Abzena Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abzena Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Abzena Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table Lonza Group Company Details
-
Table Lonza Group Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza Group Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Lonza Group Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table KBI Biopharma Company Details
-
Table KBI Biopharma Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table KBI Biopharma Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table KBI Biopharma Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table Cytovance Biologics Company Details
-
Table Cytovance Biologics Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cytovance Biologics Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Cytovance Biologics Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table Rentschler Biotechnologie Company Details
-
Table Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table Samsung Company Details
-
Table Samsung Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Samsung Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Samsung Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table Patheon Company Details
-
Table Patheon Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Patheon Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Patheon Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table Baxter Biopharma Solutions Company Details
-
Table Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table WuXi Biologics Company Details
-
Table WuXi Biologics Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table WuXi Biologics Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table WuXi Biologics Biopharmaceutical Contract Manufacturing Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Main Business and Markets Served
-
Table Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product Portfolio
-
Figure Global Growth Factors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferons Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Hormones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biopharmaceutical Contract Manufacturing Consumption Forecast by Country (2022-2028)
-
Table North America Biopharmaceutical Contract Manufacturing Consumption Forecast by Country (2022-2028)
-
Figure United States Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biopharmaceutical Contract Manufacturing Consumption Forecast by Country (2022-2028)
-
Figure Germany Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Biopharmaceutical Contract Manufacturing Consumption Forecast by Country (2022-2028)
-
Figure China Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Biopharmaceutical Contract Manufacturing Consumption Forecast by Country (2022-2028)
-
Figure Brazil Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Biopharmaceutical Contract Manufacturing Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Biopharmaceutical Contract Manufacturing Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Biopharmaceutical Contract Manufacturing Consumption Forecast by Country (2022-2028)
-
Figure Australia Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Biopharmaceutical Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-